cis-tetracosenoyl sulfatide (GRI Bio)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namecis-tetracosenoyl sulfatide (GRI Bio)
Drug Alias Namecis-tetracosenoyl sulfatide (GRI Bio)cis-tetracosenoyl sulfatide (Glycoregimmune)cis-tetracosenoyl sulfatide (Glycoregimmune)cis-tetracosenoyl sulfatideGRI-002
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImmunomodulatorsNatural killer T-lymphocyte stimulants
TargetsUpdating
Therapy Area/IndicationsAutoimmune DiseasesReperfusion InjuryAmyotrophic Lateral Sclerosis +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTorrey Pines Institute For Molecular Studies
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTorrey Pines Institute For Molecular StudiesGri Bio Inc
Active IndicationsN/A
Inactive IndicationsAutoimmune DiseasesReperfusion InjuryAmyotrophic Lateral Sclerosis +[4] 

Other Information

ATC CodeN/A
Related LinksN/A